PHOENIX PHARMALABS, INC.
WOODS CROSS, UT, 84087-2316
|# of Employees:||5|
|Socially and Economically Disadvantaged:||N|
DESCRIPTION (provided by applicant): This Phase I application requests funds to support the continued preclinical evaluation of a novel opioid analgesic, PPL-103, and the synthesis and initial pre ...SBIRPhase I2011Department of Health and Human Services
DESCRIPTION (provided by applicant): This SBIR grant is sought for the purpose of commercializing a promising and needed drug NIH 10497(D-1). It is a novel, orally active opioid with a unique chiral ...SBIRPhase I2004Department of Health and Human Services